Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Invasive Breast Cancer × Carboplatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 154 Ovarian Neoplasms 53 Lung Neoplasms 50 Breast Neoplasms 29 Small Cell Lung Carcinoma 28 Fallopian Tube Neoplasms 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Carcinoma, Ovarian Epithelial 19 Uterine Cervical Neoplasms 18 Triple Negative Breast Neoplasms 16 Carcinoma 15 Neuroblastoma 14 Squamous Cell Carcinoma of Head and Neck 13 Neoplasm Metastasis 12 Endometrial Neoplasms 12 Neoplasms 10 Adenocarcinoma of Lung 9 Recurrence 8 Head and Neck Neoplasms 8 Central Nervous System Neoplasms 7 Carcinoma, Transitional Cell 7 Brenner Tumor 7 Peritoneal Neoplasms 6 Esophageal Neoplasms 6 Urinary Bladder Neoplasms 5 Testicular Neoplasms 5 Teratoma 4 Seminoma 4 Mesothelioma 4 Lung Diseases 4

Interventions

Trastuzumab 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 pertuzumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Lapatinib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡